RESUMO
Fitz-Hugh-Curtis syndrome (FHCS) is defined as inflammation on the surface of the liver following sexually transmitted chlamydia infection. We successfully observed the microvascular structure of the inflamed portion between the abdominal wall and surface of the liver in an elderly patient with FHCS using a superb microvascular imaging (SMI) system, a new technology developed for observing minute vascular flow. An 80-year-old Japanese female with right dorsal to lateral abdominal pain and fever came to our hospital. Anti-chlamydia antibodies were positive. SMI revealed signals suggesting small vessels passing from the liver surface to the hypoechoic space.
Assuntos
Infecções por Chlamydia/diagnóstico por imagem , Hepatite/diagnóstico por imagem , Microvasos/diagnóstico por imagem , Doença Inflamatória Pélvica/diagnóstico por imagem , Peritonite/diagnóstico por imagem , Ultrassonografia , Dor Abdominal/diagnóstico por imagem , Parede Abdominal , Idoso de 80 Anos ou mais , Infecções por Chlamydia/fisiopatologia , Meios de Contraste , Diagnóstico Diferencial , Feminino , Hepatite/fisiopatologia , Humanos , Fígado , Microvasos/fisiopatologia , Doença Inflamatória Pélvica/fisiopatologia , Peritonite/fisiopatologiaRESUMO
The efficacy of repeated lusutrombopag administration for thrombocytopenia in patients with chronic liver disease who undergo two or more planned invasive procedures is unknown. We herein report our findings regarding the effects of repeated lusutrombopag administration given to avoid platelet transfusion in a patient with chronic liver disease and thrombocytopenia. The platelet count showed a positive response to lusutrombopag treatment prior to the initial invasive procedure to treat a hepatoma, so platelet transfusion was not necessary. In conclusion, lusutrombopag may be a useful drug for patients with thrombocytopenia to avoid platelet transfusion in those undergoing two or more planned invasive procedures.
